UK G4-1 for Solid Tumor Treatment

G4-1 - Drug designed to bind to proteosome

G4-1 inhibits tumor growth better than FDA-approved carfilzomib

Miller et al. (2015) J. Med. Chem 68:2036-41

Other Programs

Silo Pharma – PsylocybinTreatment in Cancer Patients

Wake Forest’s KPC34 for AML and ALL

Scroll to Top


You are about to review presentations, reports and/or filings of AIkido Pharma Inc., that contain time-sensitive information. The information contained therein is only accurate as of the date thereof. AIkido Pharma Inc. will not be reviewing or updating the material that is contained in these items after the date thereof. The information contained therein may be updated, amended, supplemented or otherwise altered by subsequent presentations, reports and/or filings by AIkido Pharma Inc.